Our Services

Our High-Content imaging is a powerful platform designed to accelerate drug discovery and biomarker development. Utilizing advanced microscopy and image analysis technologies, we capture detailed, multi-parametric data from complex biological samples at the single-cell level. By generating rich, actionable data, our service empowers scientists to make informed decisions in the early stages of drug development, efficiently identifying promising compounds and potential therapeutic targets.

Our Multiplex Tissue Imaging Service provides unparalleled insight into the complex cellular environment of tissue samples. Utilizing advanced imaging technologies, we can simultaneously detect and analyze multiple protein targets within a single tissue section, preserving the spatial context of their interactions. This high-resolution approach enables researchers to visualize how different cell types and markers are organized and related to one another within the tissue architecture.

The Reverse Phase Protein Array (RPPA) enables precise quantification of protein levels in biological samples. RPPA is a valuable tool for large-scale protein expression profiling, biomarker discovery, and elucidating signaling pathway activities in various biomedical research contexts. Leveraging this technology, we can identify therapeutic targets, enhance individualized treatment strategies, and monitor patient responses to therapies, thus contributing to the advancement of personalized medicine in oncology.

Our Patient-Derived Xenograft (PDX) service offers a powerful platform for personalized cancer research using super-immunocompromised mice as host models. We implant patient-derived tumor tissues into these specialized mice, creating a robust and physiologically relevant environment for studying cancer progression and treatment responses. Our super-immunocompromised mice are carefully engineered to have extremely reduced immune responses, enabling the successful engraftment of diverse human tumors without rejection.

Our Organoid Biobank is a cutting-edge resource offering a diverse collection of cancer organoids, encompassing major cancer types including colorectal, ovarian, breast, thyroid, and pancreatic. These organoids, derived from patient tissues, faithfully recapitulate the complex 3D architecture and genetic landscape of their parent tumors, providing an exceptional platform for translational research. With our Organoid Biobank, we are empowering scientists to advance our understanding of cancer and accelerate the development of new and effective therapies.

DSP GeoMx service offers a revolutionary approach to spatial transcriptomics, enabling researchers to directly visualize and analyze RNA within the context of tissue architecture. By harnessing the GeoMx platform, we can generate high-resolution, spatially-resolved gene expression data from a diverse array of sample types. Trust us to empower your research with precise, reliable, and actionable data that brings your findings from observation to discovery.